We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Only Negligible Evidence Exists That Salt Raises Blood Pressure

By HospiMedica International staff writers
Posted on 27 Dec 2012
The evidence for any health benefits associated with salt reduction is controversial and the "concealment of scientific uncertainty" is a mistake, claims a new study.

Researchers at Columbia University (New York, NY, USA) explored the development of the scientific controversy over the quality of the evidence implicating dietary salt in disease, which goes back to the early part of the 20th century. More...
The researchers noted that most of the evidence pointed to the weakest of correlations between salt and blood pressure. Despite this, the cause to reduce salt was taken up rapidly by public health leaders at local, national, and international levels that pressed the case for salt reduction at the population level.

The researchers cited several studies that could not find a link between salt intake and elevated blood pressure. Examples of such studies include the 1967 study of the Framingham cohort, and Japanese and Scottish reports in the 1980s totaling 15,000 people that concluded the association between sodium and blood pressure is extremely weak. Another example is a 2011 Cochrane Review study that examined more than 150 randomized controlled trials and 13 population studies, which concluded, “Without an obvious signal in favor of sodium reduction, another position could be to accept that such a signal may not exist.”

Such studies usually face fierce opposition or even ridicule among peers. For example, in May 2011, the Journal of the American Medical Association (JAMA) published a study by Katarzyna Stolarz-Skrzypek, MD, PhD, and colleagues that found only a weak correlation between salt and blood pressure. A subsequent editorial in the Lancet criticized the JAMA study as likely to confuse public perceptions of the importance of salt as a risk factor for high blood pressure, heart disease, and stroke. The authors cited many more studies finding little association between salt and blood pressure that did not eliminate the stigma attached to the mineral.

“Science must remain open, skeptical, and concerned about unmeasured confounding and selection bias in studies that accompany even the best efforts to articulate the evidence for new interventions,” concluded lead author Ronald Bayer, PhD, and colleagues of the school of public health. “The concealment of scientific uncertainty is a mistake that serves neither the ends of science nor good policy. Simplistic pictures of translation from evidence to action distort our ability to understand how policy is, in fact, made and how it should be made.”

The researchers noted that in the 1990s, C. Everett Koop, MD, the then US Surgeon General, issued a report noting that government agencies were “very quick to embrace the importance of salt reduction in the 1970s and 1980s, which stood in stark contrast for the snail's pace of recommendations related to reducing blood cholesterol levels.”

Related Links:
Columbia University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.